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Abstract: In a collection of 58 snakes comprising predominantly Eurasian vipers in Switzerland, five
snakes died unexpectedly during hibernation from 2009 to 2012. In one snake, organisms resembling
chlamydiae were detected by immunohistochemistry in multiple histiocytic granulomas. Real-time quan-
titative PCR and microarray analysis were used to determine the presence of Chlamydia pneumoniae in
tissue samples and cloacal/choanal swabs from snakes in the collection; 8/53 (15.1%) of the remaining
snakes were positive. Although one infected snake had suppurative periglossitis, infection with C. pneu-
moniae did not appear to be associated with specific clinical signs in snakes. Of seven snakes treated with
5 mg/kg marbofloxacin IM once daily, five became PCR negative for C. pneumoniae following treatment,
whereas one animal remained positive and one snake was lost to follow-up.
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 Chlamydia pneumoniae was detected in 8/53 (15%) snakes in a private collection in 25 
Switzerland. 26 
 In one snake that died, chlamydiae were detected by immunohistochemistry in 27 
multiple histiocytic granulomas. 28 
 There was no clear evidence that C. pneumoniae caused morbidity or mortality in 29 
other snakes. 30 
 There was no clear evidence that treatment with marbofloxacin effectively cleared C. 31 
pneumoniae infection from snakes. 32 
Abstract 33 
In a collection of 58 snakes comprising predominantly Eurasian vipers in Switzerland, 34 
five snakes died unexpectedly during hibernation from 2009 to 2012.  In one snake, 35 
organisms resembling chlamydiae were detected by immunohistochemistry in multiple 36 
histiocytic granulomas. Real-time quantitative PCR and microarray analysis were used to 37 
determine the presence of Chlamydia pneumoniae in tissue samples and cloacal/choanal 38 
swabs from snakes in the collection; 8/53 (15.1%) of the remaining snakes were positive. 39 
Although one infected snake had suppurative periglossitis, infection with C. pneumoniae did 40 
not appear to be associated with specific clinical signs in snakes. Of seven snakes treated with 41 
5 mg/kg marbofloxacin IM once daily, five became PCR negative for C. pneumoniae 42 
following treatment, whereas one animal remained positive and one snake was lost to follow-43 
up. 44 
 45 
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Chlamydia pneumoniae was first described in humans in association with respiratory 47 
disease and has been reported in horses, marsupials, amphibians and reptiles (Roulis et al., 48 
2013). Whilst much is known about the symptoms and treatment of C. pneumoniae in 49 
humans, there are few reports of chlamydiae in reptiles (Jacobson et al., 2004; Soldati et al., 50 
2004; Frutos et al., 2014). C. pneumoniae has been identified in granulomatous lesions in 51 
squamata (Jacobson et al., 2004; Soldati et al., 2004), but the pathogenicity of this agent 52 
remains unclear. Here, we report the detection of C. pneumoniae in a private collection of 53 
snakes, comprising Viperidae, Colubridae, Pythonidae and Elapidae, along with the 54 
diagnostic and therapeutic protocol adopted. 55 
 56 
Out of a total of 58 snakes in the collection, five (8.6%) died unexpectedly during 57 
hibernation from 2009 to 2012 (see Appendix: Supplementary Table 1). On pathological 58 
examination, a 2.5 year old female horned viper (Vipera ammodytes ammodytes) had 59 
multifocal histiocytic granulomas in the large blood vessels proximal to the cardiac atrium 60 
(Fig. 1a) and in the liver and splenopancreas. Occasional presumptive chlamydial inclusion 61 
bodies were detected in histiocytes in sections stained with haematoxylin and eosin, and the 62 
presence of Chlamydia was confirmed by immunohistochemistry using a Chlamydiaceae 63 
Family-specific monoclonal antibody directed against the chlamydial lipopolysaccharide 64 
(ACI-P, Progen Biotechnik; Fig. 1b) (Soldati et al. 2004). Samples of lung, heart, liver, 65 
splenopancreas, kidney and intestine were tested using a Chlamydiaceae Family-specific real-66 
time quantitative PCR (qPCR) and C. pneumoniae was identified using an ArrayTube 67 
microarray (Borel et al., 2008). Chlamydial infection was postulated as most likely cause of 68 
death in this snake. The other four snakes were negative for Chlamydiaceae by qPCR and did 69 




not have consistent lesions at postmortem examination (see Appendix: Supplementary Table 70 
1). 71 
 72 
Choanal/cloacal swabs from six snakes that had either direct or indirect (fomite) 73 
contact with the index case were positive for C. pneumoniae by qPCR-microarray. The 74 
remaining 47 animals in the collection were also tested. In total, C. pneumoniae was detected 75 
in choanal/cloacal swabs from 8/53 (15%) live snakes (Table 1). All samples were negative 76 
by virus isolation and PCR for paramyxoviruses and adenoviruses (Blahak, 1995). Four 77 
months after the first screening, the eight C. pneumoniae positive snakes, along with one 78 
previously negative snake sharing a cage with a positive animal, and one snake that was 79 
positive for a Chlamydiaceae (not C. pneumoniae), were retested by qPCR-microarray. While 80 
3/8 previously positive snakes became C. pneumoniae negative, the previously negative snake 81 
sharing a cage with a positive animal became positive for C. pneumoniae. 82 
 83 
Marbofloxacin was selected in an attempt to eradicate C. pneumoniae from the 84 
collection, since quinolones are used frequently in reptiles and have been shown to be 100% 85 
inhibitory for C. pneumoniae in vitro (Hammerschlag and Roblin, 2000). The seven 86 
remaining positive snakes were treated with 5 mg/kg marbofloxacin (Marbocyl FD, 87 
Vétoquinol AG) IM once daily (Table 2). Choanal/cloacal swabs were tested for chlamydiae 88 
by qPCR at the onset of treatment and every 5 days until day 35. Treatment was discontinued 89 
as soon as all snakes in the same terrarium became qPCR negative or no later than day 35 for 90 
all the other snakes, since hibernation was scheduled for day 95. At day 35, 3/7 treated snakes 91 
were negative by qPCR for all Chlamydiaceae, one snake remained positive for C. 92 




pneumoniae, one snake was positive for Chlamydiaceae (not C. pneumoniae), no sample was 93 
collected from one animal and one snake was sold. 94 
 95 
After hibernation (day 320), the entire collection (n = 45; no samples from two 96 
animals, 12 animals sold, one animal dead due to egg retention and seven new acquisitions) 97 
was retested by qPCR-microarray. The snake that had been positive for C. pneumoniae at day 98 
35 of treatment tested negative for Chlamydiaceae after hibernation; this snake had a 99 
suppurative inflammation of the tongue sheath at the first day of therapy, which eventually 100 
healed. The snake that was positive for Chlamydiaceae but negative for C. pneumoniae on 101 
day 35 remained positive after 320 days. All other snakes in the collection were negative by 102 
qPCR for chlamydiae (n = 44). 103 
 104 
In summary, 5/7 snakes infected with C. pneumoniae became negative when treated 105 
with 5 mg/kg marbofloxacin IM once daily for 35 days. Evidence of persistent shedding of C. 106 
pneumoniae in one snake despite treatment suggests that marbofloxacin might not be entirely 107 
efficacious for treatment of chlamydial infections in reptiles. The suppurative inflammation of 108 
the tongue sheath in one snake healed during marbofloxacin treatment and the animal became 109 
negative by qPCR. 110 
 111 
Previous studies (Jacobson et al., 2004; Soldati et al., 2004) found inclusion bodies in 112 
granulomas from dead snakes and identified chlamydiae by electron microscopy and 113 
immunohistochemistry, respectively; chlamydial DNA was also detected by PCR.  In our 114 
investigation, C. pneumoniae was detected in 1/5 snakes that died, while none of the other 115 
eight animals that were positive for C. pneumoniae died. These findings suggest that C. 116 




pneumoniae infections might not be necessarily lethal for snakes and are consistent with 117 
another report of clinically inconspicuous carriers (Frutos et al., 2013). This is further 118 
supported by the three cases in which infection with C. pneumoniae appeared to have resolved 119 
without antibiotic treatment. Clinical chlamydiosis in reptiles may be related to stress due to 120 
capture and transportation (Jacobson et al., 2004), high-density farming (Homer et al., 1994; 121 
Huchzermeyer et al., 2008) or, as speculated in the present study, hibernation.  122 
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Figure legends 174 
 175 
Fig. 1 (a) Histopathology of the index case (Vipera ammodytes ammodytes) that was positive 176 
for Chlamydia pneumoniae by immunohistochemistry, real-time qPCR and Arraytube 177 
microarray. Large blood vessels close to the atrium of the heart are obliterated by multifocal 178 
histiocytic granulomas (*) and thrombosis. Haematoxylin and eosin staining. (b) 179 
Immunohistochemistry for Chlamydiaceae antigen in a histological section of the heart of the 180 
index case, with red-brown granular immunostaining in the cytoplasm of histiocytes within a 181 




granuloma in the wall of a major heart vessel (*). 3-amino-9-ethylcarbazole (AEC)-182 
peroxidase method with haematoxylin counterstain. 183 
  184 




Table 1 185 
Live snakes screened by real-time quantitative PCR (qPCR) for Chlamydiaceae and 186 
ArrayTube microarray for Chlamydia pneumoniae. 187 
 188 
   Number positive by qPCR-microarray 
Species Female Male Choana Cloaca Both 
Atheris chlorechis 3 1    
Atheris nitschei 2 1    
Bitis caudalis 2 2    
Cerastes gasperettii 1 1    
Elaphe climacophora 2 1    
Lampropeltis mexicana thayeri  1 1    
Montivipera bulgardaghica 2 1  1  
Montivipera xanthina 2 3    
Morelia bredli 1 1    
Morelia viridis 1 3    
Naja naja 1 1    
Pantherophis guttatus 1 3    
Vipera ammodytes ammodytes  3 3 2  3 
Vipera ammodytes ruffoi  1 1 1   
Vipera kaznakovi 2 2    1  
Vipera transcaucasiana 1 2  (1*)  
Totals 26 27 3 1 (1) 4 
 189 
The sample marked with * was qPCR positive for Chlamydiaceae, but the species could not be identified by 190 
microarray. Snakes were fed with freshly killed mice from the owner’s breeding colony. Basking areas (35 °C) 191 
and cool zones (room temperature 20-25 °C) were maintained on a 12 h/12h circadian cycle, while relative 192 
humidity was set according to the species’ needs. All Eurasian snakes were hibernated in aerated styropore boxes 193 
in a refridgerator (Liebherr WK/GWK 611) at 8 °C and 70% relative humidity from 1 December to 1 March.  194 




Table 2 195 
Test and treatment protocol for seven snakes infected with Chlamydia pneumoniae. 196 
 197 
   Day 
Species Sex Location 0 5 10 15 20 25 30 35 320 
Vipera ammodytes M Choana + - -     - - 
  Cloaca - - -     - - 
Vipera ammodytes F Choana + - -     - - 
  Cloaca - - -     - - 
Vipera ammodytes M Choana + + a        
  Cloaca + + a        
Vipera ammodytes M Choana + + -     - - 
  Cloaca + + -     + b + b 
Vipera kaznakovi M * Choana + + -      - 
  Cloaca + + -      - 
Vipera ammodytes F Choana - - -  - - + b - - 
  Cloaca + + + + + + + - - 
Vipera ammodytes F c Choana + + + + b - - - - - 
  Cloaca + + + + + + + + - 
 198 
The presence of Chlamydiaceae was determined by qPCR and C. pneumoniae was confirmed by ArrayTube 199 
microarray. Empty cells indicate that no test was performed. Snakes were treated with 5 mg marbofloxacin IM 200 
once daily (grey shading) from day 1 until tested negative or to day 35 if they remained positive. Hibernation 201 
was imposed from day 95 to day 320. 202 
a Snake was sold. 203 
b Chlamydial species could not be identified by Arraytube Microarray. 204 
c This snake had suppurative inflammation of the tongue sheath at the first day of therapy. None of the other 205 
snakes exhibited clinical signs.206 
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